Mon, September 23, 2024

Joseph Catanzaro Maintained (BDTX) at Buy with Increased Target to $15 on, Sep 23rd, 2024

Joseph Catanzaro of Piper Sandler, Maintained "Black Diamond Therapeutics, Inc." (BDTX) at Buy with Increased Target from $12 to $15 on, Sep 23rd, 2024.

Joseph has made no other calls on BDTX in the last 4 months.



There are 3 other peers that have a rating on BDTX. Out of the 3 peers that are also analyzing BDTX, 0 agree with Joseph's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Joseph


  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $11 on, Wednesday, September 18th, 2024
  • Robert Driscoll of "Wedbush" Reiterated at Buy and Held Target at $16 on, Tuesday, September 10th, 2024
  • Laura Prendergast of "Raymond James" Initiated at Buy and Held Target at $20 on, Wednesday, July 31st, 2024